Mifepristone versus laminaria: a randomized controlled trial of cervical ripening in midtrimester termination

Contraception

Volumn 76, Issue 5, 2007, Pages 383-388

  Prairie, Beth A ^a   Lauria, Michele R ^a   Kapp, Nathalie ^a   MacKenzie, Todd ^a   Baker, Emily R ^a   George, Karen E ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Abortion; Mifepristone; Randomized controlled trial; Second trimester termination

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADULT; ANEUPLOIDY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DRUG MEGADOSE; FEMALE; FETUS MALFORMATION; GESTATIONAL AGE; HUMAN; INTERMETHOD COMPARISON; LABOR INDUCTION; LABOR PAIN; LAMINARIA; MATERNAL AGE; PARITY; PLACENTA PREVIA; PREGNANCY TERMINATION; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER ABORTION; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE; UTERINE CERVIX RIPENING; VISUAL ANALOG SCALE;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADULT; CERVICAL RIPENING; FEMALE; HUMANS; LABOR, INDUCED; LAMINARIA; MIFEPRISTONE; MISOPROSTOL; PAIN; PREGNANCY; PREGNANCY TRIMESTER, SECOND; TIME FACTORS;

EID: 35348931039     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.07.008     Document Type: Article

References (23)

1. Schultz K.F., Grimes D.A., and Cates Jr. W. Measures to prevent cervical injury during suction curettage abortion. Lancet 1 (1983) 1182-1185
2. World Health Organization. Method of abortion after 14 weeks gestation. WHO technical report series on medical methods for termination of pregnancy (1997), WHO Scientific Group on Medical Methods for Termination of Pregnancy, Geneva
3. Blumenthal P.D., Castleman L.D., and Jain J.K. Abortion by labor induction. In: Paul M., Lichtenberg E.S., Borgatta L., Grimes D.A., and Stubblefield P.G. (Eds). A clinician's guide to medical and surgical abortion (1999), Churchill Livingston, New York 139-154
4. Blumenthal P.D. Prospective comparison of Dilapan and laminaria for pretreatment of the Cervix in second trimester induced abortion. Obstet Gynecol 72 (1988) 243-246
5. Riskin-Mashiah S., and Wilkins I. Cervical ripening. Obstet Gynecol Clin North Am 26 (1999) 243-257
6. Cabrol D., Dubois C., Cronje H., et al. Induction of labor with mifepristone (RU-486) in intrauterine fetal death. Am J Obstet Gynecol 163 (1990) 540-542
7. Schaff E., Fielding S.L., Westhoff C., et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortions. JAMA 284 (2000) 1948-1953
8. Tang O., and Ho P.C. Medical abortion in the second trimester. Best Pract Res Clin Obstet Gynaecol 16 (2002) 237-246
9. Neilson J.P. Mifepristone for the induction of labour. Cochrane Database Syst Rev 4 (2000) CD002865
10. Wong D.L., and Baker C.M. Pain in children: comparison of assessment scales. Pediatr Nurs 14 (1988) 9-17
11. Elam-Evans L.D., Strauss L.T., Herndon J., Parker W., Bowens S., and Zane S.C. Abortion surveillance - United States 2000. MMWR CDC Surveill Sum 52 (2003) 1-32
12. Peterson W.F., Berry F.N., Grace M., and Gulbranson C. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet Gynecol 62 (1983) 185-190
13. Grimes D.A. The continuing need for late abortions. JAMA 280 (1998) 747-750
14. Swahn M.L., and Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br J Obstet Gynaecol 95 (1988) 126-134
15. Stenlund P.M., Eckman G., Aedo A.R., and Bygdeman M. Induction of labor with mifepristone: a randomized, double-blind study versus placebo. Acta Obstet Gynecol Scand 78 (1999) 793-798
16. Ho P.C., Tsang S.S., and Ma H.K. Reducing the induction to abortion interval in termination of second trimester pregnancies: a comparison of mifepristone with laminaria tent. Br J Obstet Gynaecol 102 (1995) 648-651
17. Goh S.E., and Thong K.J. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Contraception 73 (2006) 516-519
18. Stubblefield P.G., Carr-Ellis S., and Borgatta L. Methods for induced abortion. Obstet Gynecol 104 (2004) 174-185
19. Borgatta L., Chen A.Y., Vragovic O., Stubblefield P.G., and Magloire C.-A. A randomized clinical trial of the addition of laminaria to misoprostol and hypertonic saline for second-trimester induction abortion. Contraception 72 (2005) 358-361
20. Jain J.K., and Mishell Jr. D.R. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. N Engl J Med 331 (1994) 290-293
21. Fischer M., Bhatnagar J., Guarner J., et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 353 (2005) 2352-2360
22. Food and Drug Administration. Public health advisory. Sepsis and medical abortion (2005), FDA, Rockville (MD)
23. Fiala C., Swahn M., Stephansson O., and Gemzell-Danielsson K. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation. Hum Reprod 20 (2005) 3072-3077